This grant supports early-career, innovative breast cancer researchers with leadership potential, requiring collaboration with consumer advocates and a significant time commitment to impactful research.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 24, 2026 (Pre-Application/LOI) | July 8, 2026 (Full Application) | July 13, 2026 (Letters of Recommendation & Verification)
Funding Amounts: Up to $4.9M total costs over 4 years; 1 anticipated award.
Summary: Supports exceptionally creative early-career scientists with leadership potential to advance innovative breast cancer research addressing key program challenges.
Key Information: PI must commit ≥25% effort; team must include ≥2 breast cancer consumer advocates.
This award from the Department of Defense Breast Cancer Research Program (BCRP) is designed to support early-career, independent investigators who demonstrate extraordinary creativity, innovation, and leadership potential in breast cancer research. The intent is to recognize and empower individuals—rather than projects—who can make transformative contributions to ending breast cancer. Applicants must propose work addressing at least one of the BCRP’s overarching challenges, which range from prevention and risk assessment to improving treatment and eliminating mortality from metastatic disease. The program encourages novel approaches from diverse disciplines, not necessarily limited to those with prior breast cancer research experience.